» Articles » PMID: 37443825

Genetic and Molecular Mechanisms in Brugada Syndrome

Overview
Journal Cells
Publisher MDPI
Date 2023 Jul 14
PMID 37443825
Authors
Affiliations
Soon will be listed here.
Abstract

Brugada syndrome is a rare hereditary arrhythmia disorder characterized by a distinctive electrocardiogram pattern and an elevated risk of ventricular arrhythmias and sudden cardiac death in young adults. Despite recent advances, it remains a complex condition, encompassing mechanisms, genetics, diagnosis, arrhythmia risk stratification, and management. The underlying electrophysiological mechanism of Brugada syndrome requires further investigation, with current theories focusing on abnormalities in repolarization, depolarization, and current-load match. The genetic basis of the syndrome is strong, with mutations found in genes encoding subunits of cardiac sodium, potassium, and calcium channels, as well as genes involved in channel trafficking and regulation. While the initial discovery of mutations in the SCN5A gene provided valuable insights, Brugada syndrome is now recognized as a multifactorial disease influenced by several loci and environmental factors, challenging the traditional autosomal dominant inheritance model. This comprehensive review aims to provide a current understanding of Brugada syndrome, focusing on its pathophysiology, genetic mechanisms, and novel models of risk stratification. Advancements in these areas hold the potential to facilitate earlier diagnosis, improve risk assessments, and enable more targeted therapeutic interventions.

Citing Articles

Brugada syndrome update.

Xu T, Wang S, Wang J, Xing J Front Physiol. 2025; 15:1520008.

PMID: 39896197 PMC: 11782167. DOI: 10.3389/fphys.2024.1520008.


Identification of a Novel gene variant in a young female with atrioventricular canal defect in the absence of classical Brugada syndrome phenotype.

Mondal R, Manna R, Banerjee E, Benito-Leon J, Deb S Med Res Arch. 2024; 12(7).

PMID: 39469427 PMC: 11515840. DOI: 10.18103/mra.v12i7.5527.


Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases.

Oh S, Mai X, Kim J, de Guzman A, Lee J, Park S Exp Mol Med. 2024; 56(5):1066-1079.

PMID: 38689091 PMC: 11148179. DOI: 10.1038/s12276-024-01222-1.


Sudden Cardiac Death in the Young: State-of-the-Art Review in Molecular Autopsy.

Salzillo C, Sansone V, Napolitano F Curr Issues Mol Biol. 2024; 46(4):3313-3327.

PMID: 38666937 PMC: 11049009. DOI: 10.3390/cimb46040207.


Primary Electrical Heart Disease-Principles of Pathophysiology and Genetics.

Badura K, Bulawska D, Dabek B, Witkowska A, Lisinska W, Radzioch E Int J Mol Sci. 2024; 25(3).

PMID: 38339103 PMC: 10855675. DOI: 10.3390/ijms25031826.

References
1.
Sieira J, Conte G, Ciconte G, Chierchia G, Casado-Arroyo R, Baltogiannis G . A score model to predict risk of events in patients with Brugada Syndrome. Eur Heart J. 2017; 38(22):1756-1763. DOI: 10.1093/eurheartj/ehx119. View

2.
Sidik N, Quay C, Loh F, Chen L . Prevalence of Brugada sign and syndrome in patients presenting with arrhythmic symptoms at a Heart Rhythm Clinic in Singapore. Europace. 2009; 11(5):650-6. DOI: 10.1093/europace/eup079. View

3.
McNair W, Sinagra G, Taylor M, Lenarda A, Ferguson D, Salcedo E . SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. J Am Coll Cardiol. 2011; 57(21):2160-8. PMC: 9689753. DOI: 10.1016/j.jacc.2010.09.084. View

4.
Hoogendijk M, Potse M, Vinet A, de Bakker J, Coronel R . ST segment elevation by current-to-load mismatch: an experimental and computational study. Heart Rhythm. 2010; 8(1):111-8. DOI: 10.1016/j.hrthm.2010.09.066. View

5.
Coronel R, Casini S, Koopmann T, Wilms-Schopman F, Verkerk A, de Groot J . Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation. 2005; 112(18):2769-77. DOI: 10.1161/CIRCULATIONAHA.105.532614. View